Preemptive analgesia in the “non-tube no fasting” fast track program for resectable esophageal carcinoma

Abstract

China has the highest incidence of esophageal squamous cell carcinoma in the world. The 2020 global cancer burden data released by the International Agency for Research on Cancer of the World Health Organization showed that esophageal carcinoma ranks sixth in incidence [324,000] and fourth in mortality among malignant tumors in China, accounting for 7.1% and 10% of the total number of new cancers and cancer deaths, respectively. The global 5-year survival rate of esophageal carcinoma is 15-25%. It is the

The effects of regional anesthesia combined with awake delayed extubation in patients undergoing esophageal cancer surgery: a single-blind randomized controlled trial

“…Despite improved perioperative management, the morbidity and mortality rates are still the highest after esophagectomy among all solid tumor surgeries. MIE involves dissection and trauma to large muscles, postoperative pain after MIE is still common and is a major factor affecting patients' recovery [15]. Adequate pain control can decrease PPCs, such as atelectasis or pneumonia and improve the quality of life for thoracic patients[16].…”

“…Zhang et al reported that continuous paravertebral block alleviated the pain of patients in the resting and active state for patients undergoing MIE, which enabled patients to get out of bed early, cough and sputum effectively, and decreased the incidence of pulmonary complications [7]. Postoperative pain in MIE mainly comes from the trauma of thoracic and abdomen, especially originated from the upper abdominal incision [15]. So, we applied SAPB for thoracic analgesia and used TAPB combined with RSB for abdominal analgesia.…”